Tag: RNS system
NeuroPace announces early completion of patient enrolment in NAUTILUS pivotal study
NeuroPace has announced the completion of the patient enrolment goal in its NAUTILUS pivotal study for the treatment of idiopathic generalised epilepsy (IGE) “more...
NeuroPace initiates feasibility study of responsive neurostimulation for Lennox-Gastaut syndrome
NeuroPace has announced that the first patient with Lennox-Gastaut syndrome (LGS)—a particularly severe form of childhood-onset epilepsy characterised by cognitive dysfunction and frequent seizures—was...
Why responsive neurostimulation is garnering “wide interest” from the epilepsy field
To date, thalamic responsive neurostimulation (RNS) has shown real potential in the treatment of patients with drug-resistant epilepsy. Mark Richardson (Massachusetts General Hospital, Boston,...
NeuroPace announces first patient implant in NAUTILUS pivotal study
NeuroPace has announced the first patient has been implanted in the NAUTILUS clinical trial, a pivotal study that will evaluate the safety and effectiveness...
NeuroPace announces first treatment in pivotal study evaluating RNS system in...
NeuroPace has announced that the first patient was recently treated in the RESPONSE clinical trial, which is evaluating the safety and effectiveness of the...
NeuroPace gains IDE approval to launch pivotal study of neuromodulation therapy...
NeuroPace has announced that it has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate the NAUTILUS...
